Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic acid, ATRA, and low-dose cytarabine in AML
NCT00995332Phase 2Completed
- Sponsor
- University of Bergen
- Start
- Sep 2009
- Primary completion
- Feb 2013
- Countries
- 1
01
Overview
A Phase 2 trial of valproic acid in acute myeloid leukemia (AML), sponsored by University of Bergen. Started Sep 2009; status: completed.
02
Drugs
valproic acid
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00995332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00995332.